/ News, Research

New biomarker for disease progression in multiple sclerosis (Derfuss / Kuhle Lab)


The new test that predicts disease progression in multiple sclerosis is based on a specific component of certain brain cells that can be measured in the blood. (Image: iStock)

The autoimmune disease multiple sclerosis can take a variety of courses. Determining the current and future progression of the disease is important in order to slow down its course as much as possible. Researchers at the University of Basel have presented a biomarker whose values in the blood allow such predictions.

Uni News

Original Publication